WASHINGTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has entered into a term sheet with TerraPower, a nuclear innovation company and advanced nuclear energy developer, related to the construction of a uranium enrichment facility capable of producing High Assay Low-Enriched Urani ...

融资活动 - 公司完成首次公开发行,发行1,250,000股普通股,募集资金净额为380万美元[252] - 2023年3月,公司发行3,164,557股普通股和等量认股权证,募集资金500万美元[253] - 2023年10月,公司发行9,952,510股普通股,募集资金912.95万美元[254] - 2024年7月,公司发行13,800,000股普通股,募集资金净额约3,230万美元[258] - 公司于2024年4月收到约550万美元的认股权证行权款[257] 收购活动 - 公司收购PET Labs Pharmaceuticals 51%股权,总价200万美元[259][260] - 公司收购Molybdos公司资产,总价约734,000美元[262] - 公司收购Klydon公司的硅-28生产资产,总价约364,000美元[263] 许可协议 - 公司与Klydon公司签订全面许可协议,获得ASP技术的独占许可[268][271] 租赁协议 - 公司于2021年10月12日与莫利布登加工厂所在地的业主签订了租赁协议，租期至2030年12月31日[273] - 公司于2023年4月1日与普雷托利亚生产设施的业主签订了租赁协议，初始租期至2024年3月31日,后续续签新租约至2026年2月28日[274][275] - 公司于2023年11月1日与普雷托利亚研发设施的业主签订了租赁协议，租期至2026年10月30日[276] - 公司于2023年10月收购PET Labs Pharmaceuticals后,该公司有两处租赁设施,分别用于办公和生产活动[277][278] 保险合同 - 公司于2021年10月25日与Optio Group签订了政治风险保险合同,覆盖范围包括永久性停止经营、资产剥夺、政治暴力导致的实物损坏等,保险期限3年[279] 收入确认 - 公司自2023年10月31日收购PET Labs Pharmaceuticals 51%股权后开始确认核医学剂量销售收入[316] 费用情况 - 研发费用为688,436美元,主要包括304,625美元人员相关成本、174,490美元咨询和专业费用、209,321美元设施及其他费用[317][319] - 销售、一般及管理费用为13,283,724美元,主要包括1,996,363美元人员相关成本、4,066,886美元股份支付、3,657,175美元专业服务和法律相关费用、3,563,300美元设施及其他公司费用[322][324] 流动性和资本资源 - 公司预计现有现金及现金等价物加上2024年7月发行股票的所得款项将可为公司未来至少12个月的运营和资本支出提供资金支持[329] - 公司未来资金需求将取决于多方面因素,包括新型同位素的研发进度和成本、监管审批、生产、销售和营销等[331] 其他 - 公司不存在任何资产负债表外安排[346] - 公司是一家较小的报告公司,不需要提供此项信息[348] - 财务报表中讨论了新的会计准则[347] - 公司在正常业务过程中与供应商签订合同,合同不包含最低采购承诺,可在通知期后终止[345]

Investors are always on the hunt for the next big thing. Much like the internet revolution and the current AI boom, savvy investors look to get in early on the ground floor of the next world-changing trend. I believe a few under-the-radar companies have the ambition and growth potential to possibly be those next breakout stars.Some think we could see another major technological disruption within a few years. Others believe it may take decades. But in my view, it’s worth examining a handful of businesses tha ...

WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company") today announced the closing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes sold 13,800,000 shares of its common stock, which reflects the exercise in full by the underwriter of its option to purchase up to 1,800,000 additional shares of common stock, at a public offering price of $2.50 per share, less underwriting discounts and commissions.   Th ...

WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”) today announced the closing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes sold 13,800,000 shares of its common stock, which reflects the exercise in full by the underwriter of its option to purchase up to 1,800,000 additional shares of common stock, at a public offering price of $2.50 per share, less underwriting discounts and commissions.   Th ...

Micro-cap stocks often get a bad rap, and for good reason. Many of these penny stocks are highly speculative and risky bets that can quickly go south. However, amid the sea of questionable micro-cap stocks, there are a few hidden gems with serious long-term potential. I believe the three stocks I’ll discuss today have the potential to possibly reach blue-chip status.I think it’s worth allocating a small portion of your portfolio to these stocks. While there are no guarantees in the stock market, these compa ...

ASP Isotopes (NASDAQ:ASPI) stock is down on Friday after the development stage advanced materials company announced a proposed public offering for its shares.The company hasn’t revealed the finer details of this offering just yet. That means we don’t know how many shares it will include or what they will be priced at. We also don’t know how much it expects to raise from the offering.What he do know is that ASP Isotopes intends to offer an additional 15% of shares in the offering to underwriters. This will g ...

WASHINGTON, July 12, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company") today announced the pricing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes has agreed to sell an aggregate of 12,000,000 shares of its common stock at a public offering price of $2.50 per share. The gross proceeds to ASP Isotopes from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by ...

WASHINGTON, July 12, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”) today announced the pricing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes has agreed to sell an aggregate of 12,000,000 shares of its common stock at a public offering price of $2.50 per share. The gross proceeds to ASP Isotopes from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by ...

WASHINGTON, July 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company") today announced that it has commenced an underwritten public offering of shares of its common stock. ASP Isotopes intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of its common stock sold in the offering. All of the shares in the offering are to be sold by ASP Isotopes. The offering is subject to market and other conditions, and there can ...